Skip to main content
EMR
NYSE Manufacturing

Emerson Electric Q3 FY2026: Sales Up 7%, Adjusted EPS $1.71; Tariff Refunds Boost Margins

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial Machinery Stocks · Industrial
Sentiment info
Positive
Importance info
7
Price
$155
Mkt Cap
$88.966B
52W Low
$122.635
52W High
$165.15
52W Position info
26% above low
Off High info
6.1% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

EMR sits 26% above its 52-week low of $122.635 on elevated volume (1.8× avg).

Summary

Emerson Electric reported Q3 FY2026 earnings with net sales of $4.9 billion, up 7% year-over-year, and adjusted diluted EPS of $1.71, up 13%. Results were aided by an $82 million tariff refund, and the company raised its full-year adjusted EPS guidance to approximately $6.55.


Key Events · Earnings and Guidance · EMR

  • Q3 Sales and Earnings Beat

    Net sales of $4.9B rose 7% YoY; adjusted diluted EPS of $1.71 increased 13% from $1.52 a year ago, driven by strong demand in power, LNG, and semiconductor markets.

  • IEEPA Tariff Refund Boosts Margins

    Received $82M ($0.11/share) in tariff refunds following a Supreme Court ruling, recorded in cost of sales. No additional refunds recognized; timing and amount of further refunds remain uncertain.

  • Full-Year Guidance Raised

    Fiscal 2026 outlook raised: net sales up ~5%, adjusted EPS ~$6.55 (vs. prior implied ~$6.44), operating cash flow ~$4.1B, and free cash flow ~$3.6B. Plans ~$1.0B in share repurchases and ~$1.2B in dividends.

  • Aggressive Share Repurchases

    Repurchased $898M of common stock in the first nine months of fiscal 2026, with 63.2M shares remaining under authorization. Buybacks reflect strong cash generation and confidence in the business.


Analysis · EMR · Manufacturing

Emerson delivered a strong quarter with 7% sales growth and 13% adjusted EPS growth, driven by broad-based demand in power, LNG, and semiconductor end markets. A one-time $82 million IEEPA tariff refund lifted gross margins, but underlying operating performance was solid across all segments. The company raised its full-year adjusted EPS outlook to approximately $6.55, implying continued momentum. Share repurchases of $898 million year-to-date underscore management's confidence in the business and commitment to returning capital to shareholders.

At the time of this filing, EMR was trading at $155.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $89B. The 52-week trading range was $122.64 to $165.15. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EMR - Latest Insights

EMR
Aug 04, 2026, 5:47 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $153.00
Real-time Price: $157.00 info
Change: +$4.00 (+3%) info
Market Cap: $88.966B info
EMR
Aug 04, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $155.00
Real-time Price: $157.00 info
Change: +$2.00 (+1%) info
Market Cap: $88.966B info
EMR
May 05, 2026, 4:13 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $135.02
Real-time Price: $157.00 info
Change: +$21.98 (+16%) info
Market Cap: $88.966B info
EMR
May 05, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $136.00
Real-time Price: $157.00 info
Change: +$21.00 (+15%) info
Market Cap: $88.966B info
EMR
May 04, 2026, 4:38 AM EDT
Source: Zawya
Importance Score:
7
Price at Filing: $140.65
Real-time Price: $157.00 info
Change: +$16.35 (+12%) info
Market Cap: $88.966B info